Two River

Two River
Limited liability company
Industry Private equity, venture capital
Founded 2004
Founder Joshua Kazam
Peter Kash
David Tanen
Benjamin Bernstein
Headquarters New York City, New York
Key people
Arie Belldegrun (Chairman)[1]
Products Venture capital, equity investment, investment management
Website www.tworiver.com

Two River Group Holdings is a New York-based venture capital firm and merchant bank focused on the life science sector. It specializes in investments in life science, biotechnology, and in firms focused on developing preventative and therapeutic technologies for a broad spectrum of disease areas including oncology, cardiovascular disease, neurological disorders, and companion animal health care.[2]

Two River was founded in September 2004 by partners Joshua Kazam,[3] Peter Kash, David Tanen[4] and Benjamin Bernstein.[5] Dr. Arie Belldegrun joined the firm in 2008 as chairman and partner.[6]

The firm has offices in New York City and Los Angeles.

Portfolio

Two River has invested in the following life science companies:[7]

Recent business

References

  1. "Two River Group Holdings, LLC: Board Committees". Businessweek. Retrieved 9 December 2013.
  2. "Company Overview of Two River Group Holdings, LLC", Businessweek. Retrieved on 26 June 2013.
  3. "Joshua A. Kazam", Businessweek. Retrieved on 26 June 2013.
  4. "David M. Tanen", Businessweek. Retrieved on 26 June 2013.
  5. "Benjamin Bernstein", Businessweek. Retrieved on 26 June 2013.
  6. "Dr. Arie S. Belldegrun, MD, FACS Joins Two River Group Holdings as Chairman and Partner". Reuters. 29 April 2008. Retrieved 26 June 2013.
  7. "Portfolio", Two River. Retrieved on 29 April 2014.
  8. Elliott, Peter (15 May 2013). "Kite Pharma Completes $35 Million Series A Preferred Stock Financing". iStreetWire. Retrieved 26 June 2013.
  9. "Arno Therapeutics Completes $30.7 Million Financing, Recapitalization and 1-for-8 Reverse Stock Split " The Wall Street Journal (New York). 30 October 2013. Retrieved 31 October 2013.
  10. "Capricor and Nile Therapeutics Complete Merger to Form Capricor Therapeutics, Inc. ". Bloomberg. 21 November 2013. Retrieved 9 December 2013.
  11. Ail, Pallavi (1 February 2014). "Perrigo expands further into pet care with Velcera deal". Reuters. Retrieved 29 April 2014.
  12. "Kite Pharma, Inc. Completes $50 Million Mezzanine Private Financing". MarketWatch. 28 April 2014. Retrieved 29 April 2014.
  13. "Kite Pharma (KITE) Files $115M IPO". StreetInsider. 19 May 2014. Retrieved 19 May 2014.
  14. "Kite Pharma Files Registration Statement for Proposed Initial Public Offering". Digital Journal. 19 May 2014. Retrieved 19 May 2014.
  15. Dion, Don (18 June 2014). "IPO For Kite Pharma Might Fly High". Seeking Alpha. Retrieved 18 June 2014.
  16. "12 US IPOs planned for the week of Jun 16". NASDAQ. 16 June 2014. Retrieved 18 June 2014.
  17. Calia, Michael (20 June 2014). "Kite Pharma Soars Above IPO Price on First Day of Trading". The Wall Street Journal. Retrieved 21 June 2014.
  18. "Kite Pharma (KITE) IPO Surges Higher". StreetInsider. 20 June 2014. Retrieved 21 June 2014.

External links

This article is issued from Wikipedia - version of the Wednesday, January 27, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.